Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03339895
Other study ID # KOU KAEK 2015/99
Secondary ID
Status Completed
Phase N/A
First received January 30, 2017
Last updated November 7, 2017
Start date January 1, 2016
Est. completion date January 25, 2017

Study information

Verified date November 2017
Source Kocaeli University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The first objective of this study was to compare the traditional fluid management (TFM) with PVI guided goal-directed fluid management (GDFM) in terms of controlled intraoperative fluid volume, surgical end-point fluid balance, blood lactate and serum creatinine levels. ASA I-II 70 patients included in this prospective study.


Description:

Objectives: The first objective of our study was to compare the traditional fluid management (TFM) with PVI guided goal-directed fluid management (GDFM) in terms of controlled intraoperative fluid volume, surgical end-point fluid balance, blood lactate and serum creatinine levels. Our secondary purpose was to compare the effects of different fluid regimens on the return of bowel function and the duration of hospital stay. Methods: The study included 70 American Society of Anesthesiologists (ASA) grade I and II patients, aged above 18 and undergoing elective colorectal surgery. After premedication with 0.03 mg /kg i.v. midazolam, all patients were started an i.v. infusion of 500 mL 0.9 % NaCl until the end of anesthesia induction.

After the anesthesia induction, while 0.9 % NaCl at rate of 2 mL/kg/h was infused in PVI- guided GDFM group, a 250-mL bolus gelatin injection (Gelofusine®, Barun) was administered when PVI was higher than 13 % over 5 min. While 0.9 % NaCl at rate of 4- 8 mL/kg/h was infused in TFM group, a 250-ml bolus gelatin injection (Gelofusine®, Barun) was administered when the mean arterial blood pressure (MAP) decreased below 65 mmHg. In both groups, when MAP was still < 65 mmHg after fluid bolus infusion, 5 mg i.v. bolus ephedrine was administered. The data collected during intraoperative period, such as heart rate, MAP, arterial blood gas samples (Ph, arterial oxygen pressure (PaO2), arterial carbon dioxide pressure (PaCO2), HCO3 level, hemoglobin, blood lactate level) were recorded. Hemoglobin, Na, K, Cl, serum creatinine, blood lactate and serum albumin scores were measured preoperatively, and up to 24 hours postoperative.

In the first 24 hours after surgery, oliguria (<0.5 ml / kg urine output), need for blood transfusion and the time of first bowel movement (depending on the days after surgery), length of hospital stay were recorded.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date January 25, 2017
Est. primary completion date January 1, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- > 18 age

- elective colorectal suregry

- ASA 1-2

Exclusion Criteria:

- Chronic renal disease

- Ejection fraction < 30

- arthmia

Study Design


Related Conditions & MeSH terms


Intervention

Other:
pvi-guided
pvi- guided total amount of crystalloid volume of fluid infused during colorectal surgery pvi-guided(according to pvi value) fluid infused during whole procedure 2 ml/kg/h infusion during surgery If PVI value <%13 and if MAP>65mmHg continue with 2 ml/kg/h cristalloid infusion If PVI value <%13 and if MAP>65mmHg 5 mcg efedrin intravenous bolus till MAP>65 mmHg If PVI value >%13 and MAP>65 mmHg infuse 250 ml Gelofusine bolus up to PVI value lowers to %13 every 5 minute If PVI value >%13 and MAP <65 mmHg infuse 250 ml Gelofusine bolus and 5 mcg efedrin intravenous up to PVI value lowers to %13
traditional-guided
traditional-guided total amount of crystalloid volume of fluid infused during colorectal surgery traditional-guided fluid infused during whole procedure 4-8 ml/kg/h infusion during surgery If MAP <65 mmHg or <30%of basal value, infuse 250 ml Gelofusine bolus and 5 mcg efedrin If MAP>65 mmHg no intervention

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Kocaeli University

Outcome

Type Measure Description Time frame Safety issue
Primary FLUID MANAGEMENT total fluid given during colorectal surgery two hours
See also
  Status Clinical Trial Phase
Completed NCT04095143 - Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT05070819 - Atrial Natriuretic Peptide in Assessing Fluid Status N/A
Withdrawn NCT04870073 - Retrograde Autologous Priming and Mannitol for Reducing Hemodilution in Cardiac Surgery Phase 3
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Completed NCT00852514 - The Optimization of Blood Pressure and Fluid Status Control With Eight-Polar Bioelectrical Impedance Analysis Phase 4
Completed NCT00517127 - Crystalloids Versus Colloids During Surgery Phase 4
Not yet recruiting NCT05983549 - Neutral Versus Liberal fLuId In Traumatic Brain Injury: a Randomised Controlled Trial N/A
Completed NCT03929471 - Target Weight Correction and Vascular Stiffness in Hemodialysis Patients N/A
Recruiting NCT06071026 - Hemodynamic Effects of Variations in Net Ultrafiltration Rate During Continuous Renal Replacement Therapy. N/A
Completed NCT02903316 - Predicting Fluid Responsiveness in on Pump Coronary Artery Bypass Graft Using Extra Systoles N/A
Terminated NCT02458157 - Forced Fluid Removal in High Risk Acute Kidney Injury Phase 4
Completed NCT02325856 - Application of Bioimpedance Spectroscopy in Taiwan Dialysis Patients N/A
Completed NCT01628731 - Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease Phase 3
Not yet recruiting NCT05647200 - Optimization of Prime Fluid Strategy to Preserve Microcirculatory Perfusion During Cardiac Surgery With Cardiopulmonary Bypass, Part II N/A
Completed NCT03768752 - Diastolic Dysfunction and Interstitial Lung Edema in Septic Patients
Terminated NCT03553394 - Effects of Restrictive Fluid Strategy on Postoperative Oliguric Pancreatic Surgery Patients N/A
Completed NCT06097923 - Implementation of Fluid Strategies Using Real-time Bioelectrical Analyzer in Surgical Intensive Care Unit (SICU) N/A
Recruiting NCT04215692 - Lung Ultrasound-guided Fluid Therapy in Pediatric Intensive Care Unit Patients N/A
Not yet recruiting NCT03322410 - Hydratation Status at Initiation of Peritoneal Dialysis: Study of the Role of Peritoneal Permeability N/A